{"url_path":"/sec/evoxw/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/2077954/0001213900-26-054783-index.html","accession_number":"0001213900-26-054783","cik":"0002077954","ticker":"EVOX","issuer_name":"Evolution Global Acquisition Corp","edgar_url":"https://www.sec.gov/Archives/edgar/data/2077954/0001213900-26-054783-index.html","primary_entity_key":"0002077954","primary_entity_name":"Evolution Global Acquisition Corp"},"word_count":258,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities\nand Use of Proceeds.\n\n \n\n*Unregistered Sales of Equity Securities*\n\n \n\nThere were no sales of unregistered securities during the period covered\nby this Quarterly Report. However, subsequent to the period covered by this Quarterly Report, on November 12, 2025, we consummated the\nInitial Public Offering of 24,000,000 units, which includes the full exercise by the underwriters of their over-allotment option in the\namount of 3,000,000 units, at $10.00 per unit, generating gross proceeds of $240,000,000. The securities sold in the Initial Public Offering\nwere registered under the Securities Act on registration statement on Form S-1 (File No. 333-289152 and 333-291438). The SEC\ndeclared the registration statement effective on November 12, 2025.\n\n \n\nSimultaneously with the closing of the Initial Public Offering, we\nconsummated the sale of 6,800,000 private placement warrants at a price of $1.00 per private placement warrant, in a private placement\nto the Sponsor and Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC generating gross proceeds of\n$6,800,000.\n\n \n\n*Use of Proceeds*\n\n* *\n\nFollowing the closing of our Initial Public Offering on November 12,\n2025, a total of $240,000,000 (which amount includes $9,600,000 of the deferred underwriting commission) was placed in a U.S.-based trust\naccount.\n\n \n\nTransaction costs amounted to $15,036,813, consisting\nof $4,320,000 of cash underwriting fee (net of $480,000 underwriters’ reimbursement), $9,600,000 of deferred underwriting fee,\nand $1,116,813 of other offering costs.\n\n \n\nFor a description of the\nuse of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.\n\n \n\n21"}